dacarbazine has been researched along with Paraganglioma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Del Rivero, J; Ilanchezhian, M; Jha, A; Pacak, K | 1 |
| Jessop, A; Jimenez, C; Jimenez, P; Tatsui, C; Thosani, S | 1 |
| Bertorelle, R; Ferrara, AM; Iacobone, M; Lombardi, G; Meringolo, D; Nardin, M; Opocher, G; Pambuku, A; Schiavi, F; Zagonel, V; Zovato, S | 1 |
| Araki, T; Kawasaki, H; Kusumoto, K; Ohata, K; Shigematsu, K; Shigeno, M; Takeshita, S | 1 |
| Gotoh, M; Kato, M; Kobayashi, H; Matsukawa, Y; Yamamoto, T; Yamauchi, Y; Yoshino, Y | 1 |
| Afani, L; Awada, A; Errihani, H | 1 |
| Al Ghuzlan, A; Amar, L; Baudin, E; Bertherat, J; Borget, I; Caramella, C; Chougnet, C; Déandreis, D; Deschamps, F; Dumont, F; Favier, J; Gimenez-Roqueplo, AP; Hadoux, J; Leboulleux, S; Letouzé, E; Libé, R; Loriot, C; Schlumberger, M; Scoazec, JY; Young, J | 1 |
| Alblas, G; Corssmit, EP; Dekkers, OM; Niemeijer, ND; van Hulsteijn, LT | 1 |
| Kobos, R; LaQuaglia, MP; Modak, S; Pandit-Taskar, N; Sait, S | 1 |
| Asai, S; Katabami, T; Naruse, M; Tanaka, Y; Tsuiki, M | 1 |
| Bravo, EL; Gill, I; Kalmadi, SR | 1 |
| Arai, Y; Kakimoto, K; Meguro, N; Ono, Y; Takezawa, K; Usami, M; Yoshida, T | 1 |
| Borson-Chazot, F; Giraud, S; Joly, MO; Lombard-Bohas, C; Nozières, C; Riou, JP; Scoazec, JY; Simon, C; Walter, T | 1 |
| Ichihara, A; Naruse, M; Nomura, K; Tanabe, A; Tsuiki, M; Tsumagari, A | 1 |
| Mori, R; Sano, T; Sinotou, K; Takigawa, H; Tatara, K; Taue, R; Uno, S | 1 |
5 review(s) available for dacarbazine and Paraganglioma
| Article | Year |
|---|---|
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytoreduction Surgical Procedures; Dacarbazine; Everolimus; Humans; Liver Neoplasms; Lung Neoplasms; Octreotide; Paraganglioma; Pheochromocytoma; Poly(ADP-ribose) Polymerase Inhibitors; Radiopharmaceuticals; Surgical Procedures, Operative; Vincristine | 2020 |
Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress.
Topics: Adrenal Gland Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Vincristine | 2017 |
Rectal Paraganglioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Colonoscopy; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Fatal Outcome; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Rectal Neoplasms; Reoperation; Vincristine | 2019 |
[Therapeutic management of malignant paragangliomas: an illustrative case and literature review].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytoreduction Surgical Procedures; Dacarbazine; Female; Humans; Neoplasm Recurrence, Local; Paraganglioma; Peptides, Cyclic; Positron Emission Tomography Computed Tomography; Somatostatin; Treatment Outcome | 2019 |
Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Catecholamines; Cyclophosphamide; Dacarbazine; Humans; Paraganglioma; Pheochromocytoma; Tumor Burden; Vincristine | 2014 |
10 other study(ies) available for dacarbazine and Paraganglioma
| Article | Year |
|---|---|
Temozolomide treatment of a malignant pheochromocytoma and an unresectable MAX-related paraganglioma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Alkylating; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Dacarbazine; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Temozolomide | 2018 |
[A CASE OF MALIGNANT PARAGANGLIOMA OF THE URINARY BLADDER TREATED WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE CHEMOTHERAPY AND METAIODOBENZYLGUANIDINE THERAPY].
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Dacarbazine; Disease-Free Survival; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Paraganglioma; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion; Vincristine | 2018 |
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Brain Neoplasms; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Polymerase Chain Reaction; Prognosis; Promoter Regions, Genetic; Retrospective Studies; Succinate Dehydrogenase; Survival Rate; Temozolomide; Tumor Suppressor Proteins | 2014 |
Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cytarabine; Dacarbazine; Daunorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Iodobenzenes; Leukemia, Myeloid, Acute; Male; Paraganglioma; Radiation Tolerance; Temozolomide | 2017 |
Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Paraganglioma; Pheochromocytoma; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Young Adult | 2017 |
Clinical utility of temozolomide in the treatment of malignant paraganglioma: a preliminary report.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Alkylating; Dacarbazine; Female; Humans; Middle Aged; Paraganglioma; Temozolomide | 2009 |
[Malignant paraganglioma responsive to CVD therapy and radiation therapy : a case report].
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Humans; Male; Middle Aged; Paraganglioma; Vincristine | 2009 |
A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Dacarbazine; Deoxycytidine; Drug Synergism; Fluorouracil; Humans; Immunohistochemistry; Male; Paraganglioma; Retroperitoneal Neoplasms; Succinate Dehydrogenase; Temozolomide; Treatment Outcome | 2012 |
Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Vincristine | 2013 |
A case of pelvic malignant paraganglioma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pelvic Neoplasms; Radionuclide Imaging; Vincristine | 2001 |